NCT00000176

Alzheimer's Disease Prevention Trial

Alzheimer's Disease Prevention Trial. A Multi-center, Randomized, Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimer's Disease and Loss of Memory in Women.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: —
• Sponsor: National Institute on Aging (NIA) · NIH
• Sex: Female
• Age: 65 Years
• Healthy volunteers: Accepted

Summary

This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.

Detailed description

PREventing Postmenopausal memory loss and Alzheimer's with Replacement Estrogens (PREPARE) is a double-blind-placebo controlled trial to determine whether estrogen (or estrogen and progesterone) can delay the onset of memory loss or Alzheimer's Disease in elderly women with a family history of the disease.

Conditions

• Alzheimer Disease
• Memory Disorders

Interventions

Type	Name	Description
DRUG	Estrogen
DRUG	Estrogen and Progesterone

Timeline

• Primary completion: 2007-09-01
• Completion: 2007-09-01
• First posted: 1999-11-01
• Last updated: 2010-11-05

Locations

22 sites across 1 country: United States